Rahul Sharma (Editor)

Medpace

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Type
  
Public

Area served
  
35 countries

Parent organization
  
Medpace Holdings Inc

Traded as
  
NYSE: MEDP

Founded
  
1992

Medpace httpswwwmdsolcomsitesdefaultfilesMedpace

Industry
  
Contract Research Organization

Key people
  
Dr. August J. Troendle, President and CEO

Products
  
Support services for pharmaceutical and medical device

Headquarters
  
Cincinnati, Ohio, United States

Subsidiaries
  
Medpace Medical Device, Inc.

Profiles

Medpace


Medpace (alt. MedPace) is a midsize, clinical contract research organization (CRO) based in Cincinnati, Ohio.

Contents

Medpace provides services for Phase I-IV of drug and medical device development services including regulatory services and central laboratory services.

In February 2014, Medpace was sold to private equity firm Cinven by CCMP Capital for around $900 million.

On August 11, 2016 Medpace (MEDP) went public with an IPO consisting of 8,050,000 shares.

Medpace a global full service cro dr august troendle medpace ceo


History

Medpace was founded in 1992 in Cincinnati, Ohio as Medical Research Services by Dr. August Troendle with several partners. Dr. Troendle first became interested in the CRO sector after working in both the regulatory and pharmaceutical area. He began his career specializing in the development of lipid lowering therapies to treat high cholesterol as a reviewer with the FDA.

Medpace with a team of industry physicians, Dr. Jonathan Issacsohn and Dr. Evan Stein completed many early studies while at Medpace and Medpace Reference Laboratories on the use of statin therapies for the treatment of hypercholesterolemia. Another Medpace physician, Dr. David Orloff is regarded as an industry opinion leader in the study of metabolic diseases - most specifically diabetes and obesity. Dr. Troendle was honored for his work as a Medpace founder in 2012 by the Cincinnati Chamber of Commerce.

Medpace completed construction on a new campus in 2012 in Madisonville, a village in the city of Cincinnati. This was a project completed in cooperation with Madisonville, the City of Cincinnati Department of Economic Development, and the State of Ohio. The project encompassed revitalizing an urban brownfield site formerly occupied by NuTone, and creating a state of the art LEED certified campus.

Recognition

In May 2009, Medpace was recognized by CenterWatch, a CRO industry publication as a top CRO by investigative sites.

In 2011 and 2012 Medpace was given the Eagle Award, an industry award by investigative sites for criteria including professionalism, partnership, efficiencies and financial considerations

Acquisitions

  • 2007-Medpace acquires Monax in the Czech Republic
  • 2009-Medpace acquires PharmaBrains AG in Switzerland
  • 2010-Medpace acquires Symbios, a medical device consultancy in Minneapolis, MN
  • 2010-Medpace acquires Medical Consulting Dr. Schlichtiger, GmbH, in Germany
  • 2012-Medpace acquires MediTech BV, a medical device consultancy in the Netherlands.
  • References

    Medpace Wikipedia